220 Biotech Companies to Present at International BIO 2002 Business Forum

  • Contact: Peper Long
    (202) 962-9200
  • Recommend
  • Tweet
  • Print
  • Email

WASHINGTON, D.C. (May 1, 2002) – Biotechnology companies from 12 countries will convene in Toronto to participate in the BIO 2002 International Biotechnology Convention & Exhibition’s fourth annual Business Forum. Of the 220 companies, 56 are Canadian. This full-scale, international investor and partnering forum offers investors and corporate partners the opportunity to learn about exciting new products and companies in health-care, agricultural, industrial and environmental biotechnology. BIO 2002 will take place June 9-12 at the Metro Toronto Convention Centre, in Toronto, Ontario.

The 230 companies, listed below, will describe their technologies, products and business plans during 15-minute presentations, which will be grouped according to technology in three simultaneous tracks. In addition to the presentations, BIO has scheduled more than 1,000 separate meetings between featured companies and potential partners and investors.

“The Business Forum will provide an opportunity for investors and pharmaceutical executives to evaluate early-stage companies with promising new technologies and products, as well as mid- and late-stage companies that have products in advanced testing,” said Morrie Ruffin, BIO’s vice president for business development and emerging companies.

The 12 countries represented in the Business Forum are Australia, Austria, Canada, Denmark, Finland, France, Germany, Israel, the Netherlands, Switzerland, the United Kingdom and the United States.

BIO 2002 registration for approved, credentialed media is complimentary, and advance registration is encouraged. All freelancers must register in advance. To register please visit www.bio.org. In order to ensure housing, reporters are urged to register as soon as possible.

BIO represents more than 1,000 biotechnology companies, academic institutions,
state biotechnology centers and related organizations in all 50 U.S. states and 33 other nations. BIO members are involved in the research and development of health-care, agricultural, industrial and environmental biotechnology products.

BIO 2002 Business Forum Presenting Companies
Canada
Active Pass Pharmaceuticals
Aegera Therapeutics Inc.
Aterna Laboratories Inc.
Affinium Pharmaceuticals
Angiongene Inc.
Angiotech Pharmaceuticals Inc.
AnorMED Inc.
Arius Research, Inc.
Axcan Pharma Inc.
Biomira Inc.
Bioniche Life Sciences Inc.
Biovail Pharmaceuticals Inc.
Caprion Pharmaceuticals Inc.
Celator Technologies Inc.
Celmed Biosciences Inc.
Chromos Molecular Systems Inc.
Chronogen Inc.
ConjuChem Inc.
Cytochroma Inc.
Cytovax Biotechnologies Inc.
Delex Therapeutics Inc.
Diabetogen Biosciences Inc.
Gemin X Biotechnologies Inc.
Generex Biotechnology Corp.
GlycoDesign Inc.
Hemosol Inc.
IatroQuest Corporation
IMI International Medical Innovations Inc.
Inex Pharmaceuticals Corporation
Inflazyme Pharmaceuticals Ltd.
Isotechnika Inc.
Kinetek Pharmaceuticals, Inc.
Labopharm Inc.
Lorus Therapeutics Inc.
MDS Inc.
MDS Proteomics Inc.
Medicago Inc.
MethylGene Inc.
Micrologix Biotech Inc.
Molecular Mining Corporation
Neurochem Inc.
NeuroMed Technologies Inc.
Origenix Technologies Inc.
PhageTech Inc.
ProMetic Life Sciences Inc.
QLT Inc.
SemBioSys Genetics Inc.
Syn-X Pharma Inc.
TGN Biotech Inc.
Transition Therapeutics Inc.
Vasogen Inc.
Viron Therapeutics Inc.
Viventia Biotech Inc.
VSM MedTech Ltd.
Xenon Genetics Inc.
Xillix Technologies Corp.

Australia
Acrux Ltd.
Amrad Corporation Limited
Bionomics, Limited
Cerylid Biosciences Ltd.
CopyRat Pty Ltd
ES Cell International Pte Ltd
pSividia Limited

Austria
igeneon AG
Intercell Biomedical Research & Development

Denmark
NeuroSearch A/S

Finland
BioTie Therapies Corp.
Galilaeus Oy
Hormos Medical Corporation
Juvantia Pharma Ltd.
France
Flamel Technologies, S.A.
Gene-IT
Genfit
GenOdyssee SA
IDM, S.A.
Neurotech, S.A.
NicOx, S.A.
OPTIS France S.A.
SEDAC Therapeutics
UroGene S.A.

Germany
Axaron Bioscience AG
Axxima Pharmaceuticals AG
Biofrontera Pharmaceuticals AG
Epigenomics AG
GPC Biotech AG
Graffinity Pharmaceuticals AG
Ingenium Pharmaceuticals AG
LION Bioscience AG
MediGene AG
MetaGen Pharmaceuticals GmbH
NOXXON Pharma AG
Peptor GmbH
Wilex Ag
Xantos Biomedicine AG

Israel
Ester Neurosciences Ltd.

Switzerland
AXOVAN AG
Cytos Biotechnology AG
ESBATech AG
Modex Therapeutics

United Kingdom
Alizyme plc
Astex Technology Ltd
BioVex Limited
British Biotech
Cyclacel Limited
Elan Biopharmaceuticals Europe
KS Biomedix Holdings Plc
Microscience Limited
Oxford Biomedical Limited
RiboTargets Ltd.
Xenova Group plc

United States
Achillion Pharmaceuticals, Inc.
Acusphere, Inc.
Aderis Pharmaceuticals, Inc.
Advanced Life Sciences
Agensys, Inc.
Albany Molecular Research, Inc.
Allos Therapeutics, Inc.
Anadys Pharmaceuticals, Inc.
Applied Molecular Evolution, Inc.
Ardais Corporation
Ardent Pharmaceuticals, Inc.
Array BioPharma Inc.
Athersys, Inc.
AVANT Immunotherapeutics, Inc.
BattellePharma, Inc.
Beyond Genomics, Inc.
Biolex, Inc.
BioMedicines
BioTransplant Incorporated
Cell Genesys, Inc.
Cepheid
CEPTYR, Inc.
Cetek Corporation
ChemoCentryx, Inc.
Corvas International, Inc.
CuraGen Corporation
Cytokinetics, Inc.
Deltagen, Inc.
Dendreon Corporation
DepoMed, Inc.
DOR BioPharma, Inc.
DrugAbuse Sciences, Inc.
Dyax Corp.
Elixir Pharmaceuticals, Inc.
EntreMed, Inc.
Epicyte Pharmaceutical, Inc.
Epimmune Inc.
EPIX Medical, Inc.
eXegenics Inc.
ExonHit Therapeutics Inc.
FibroGen, Inc.
First Genetic Trust, Inc.
Genaissance Pharmaceuticals, Inc.
GeneFormatics Incorporated
Genelabs Technologies, Inc.
Genencor International, Inc.
GenStar Therapeutics Corporation
Genta Incorporated
Genzyme Transgenics Corporation
GlycoGenesys, Inc.
Gryphon Sciences
Guilford Pharmaceuticals Inc.
Hollis-Eden Pharmaceuticals, Inc.
Human Genome Sciences, Inc.
Hyseq Pharmaceuticals, Inc.
Icagen, Inc.
Idun Pharmaceuticals, Inc.
Immusol
Inhale Therapeutic Systems, Inc.
Inhibitex, Inc.
InterMune Pharmaceuticals, Inc.
Iomai Corporation
Isotope Solutions Group, Inc.
Koronis Pharmaceuticals, Inc.
Lexicon Genetics Incorporated
LifePoint, Inc.
Ligand Pharmaceuticals Incorporated
Locus Discovery Inc.
MaxCyte, Inc.
MAXIA Pharmaceuticals, Inc.
Maxim Pharmaceuticals Inc.
Memory Pharmaceuticals Corp.
MERIX Bioscience, Inc.
Metabasis Therapeutics, Inc.
Mojave Therapeutics, Inc.
Monoclonal Antibody Therapeutics Inc.
Nanogen, Inc.
Nephros Therapeutics, Inc.
Nereus Pharmaceuticals, Inc.
Neurobiological Technologies, Inc.
NewBiotics, Inc.
Orchid Biosciences, Inc.
Nobex Corporation
Northwest Biotherapeutics, Inc.
Onyx Pharmaceuticals, Inc.
Oxigene, Inc.
Paratek Pharmaceuticals, Inc.
Pharmos Corporation
PPL Therapeutics Inc.
Protiva Biotherapeutics Inc.
PTC Therapeutics, Inc.
RenalTech International, LLC
Ribozyme Pharmaceuticals, Inc.
Ricerca, LLC
Sangamo BioSciences, Inc.
Sequella, Inc.
Stressgen Biotechnologies Corp
Structural Bioinformatics Inc.
Structural GenomiX, Inc.
Targacept, Inc.
Target Discovery, Inc.
TransMolecular, Inc.
Tripos, Inc.
Tularik Inc.
Valenits
Variagenics, Inc.
Vical Incorporated
XTL Biopharmaceuticals Ltd.
ZYCOS Inc.

Netherlands
Crucell N.V.

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.